In vitro investigation of the effect of plasticizers on the blood compatibility of medical grade plasticized poly (vinyl chloride)

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 8, 2013, Pages 1985-1992

  Zhong, Rui ^a   Wang, Hong ^a   Wu, Xia ^a   Cao, Ye ^a   He, Zeng ^a   He, Yuliang ^a   Liu, Jiaxin ^a  

^a INSTITUTE OF BLOOD TRANSFUSION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD COMPATIBILITY; COAGULATION SYSTEM; COMPLEMENT ACTIVATIONS; DI-2-ETHYLHEXYL PHTHALATE; EFFECT OF PLASTICIZERS; INCUBATION TIME; PLATELET ACTIVATION; SIGNIFICANT DIFFERENCES;

BLOOD; CARBOXYLATION; CHLORINE COMPOUNDS; FUNCTIONAL POLYMERS; PLASTICIZERS; REINFORCED PLASTICS; SOLVENTS; TUBING;

POLYVINYL CHLORIDES;

BLOOD CLOTTING FACTOR 9; CARBOXYLIC ACID DERIVATIVE; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; PADGEM PROTEIN; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PLASTICIZER; POLYVINYLCHLORIDE;

ARTICLE; BLOOD CLOTTING; BLOOD COMPATIBILITY; CAPILLARY TUBE; COMPLEMENT ACTIVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; IN VITRO STUDY; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME; SHEAR RATE; THROMBOCYTE ACTIVATION; WETTABILITY; ZETA POTENTIAL;

BLOOD COAGULATION; COMPLEMENT ACTIVATION; COMPLEMENT C3A; DIETHYLHEXYL PHTHALATE; HUMANS; MATERIALS TESTING; MODELS, BIOLOGICAL; P-SELECTIN; PLASTICIZERS; PLATELET ACTIVATION; PLATELET-RICH PLASMA; POLYVINYL CHLORIDE; SURFACE PROPERTIES; WETTABILITY;

EID: 84880836929     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-4950-1     Document Type: Article

References (34)

1. Van Dooren AA. PVC as pharmaceutical packaging material. Pharmaceutisch Weekblad. 1999;13:109-18.
2. Rahman M, Brazel CS. The plasticizer market: an assessment of traditional plasticizers and research trends to meet new challenges. Prog Polym Sci. 2004;29:1223-48.
3. Sampson J, Korte D. DEHP-plasticised PVC: relevance to blood services. Transfus Med. 2011;21:73-83.
4. AuBuchon JP, Estep TN, Davez RJ. The effect of the plasticizer di-(2-ethylhexyl)phtalate on the survival of stored RBC's. Blood. 1988;71:448-52.
5. Labow S, Card RT, Rock G. The effect of the plasticizer di(2-ethylhexyl)phthalate on red cell deformability. Blood. 1987;70:319-23.
6. Center for Devices and Radiological Health. Safety assessment of di(2-ethylhexyl)phthalate (DEHP) released From PVC Medical Devices. U.S. Food and Drug Administration. http://www.fda.gov/downloads/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/UCM080457.pdf.
7. Beth HS, Kathleen G, Christopher DH. 2-(Diethylhexyl)phthalate in blood bags: is this a public health issue? Transfusion. 2011;51:2510-7.
8. Brian LW. An innovative plasticizer for sensitive applications. J Vinyl Add Tech. 2003;9:172-6.
9. Otter R, Goth H. Hexamoll ® DINCH - our response to the plasticiser challenge. Presentation at the Conference Plasticiser 2004, Brussels.
10. Juliane S, Rosa V, Jordi S. Progress in the removal of di-[2-ethylhexyl]-phthalate as plasticizer in blood bags. Transfus Med Rev. 2012;26:27-37.
11. Zhao XB, Courtney JM. Influence on blood of plasticized polyvinyl chloride: significance of the plasticizer. Artif Organs. 1999;23:104-7.
12. Yin HQ, Zhao XB, Courtney JM. Blood interactions with plasticized poly(vinyl chloride): relevance of plasticizer selection. J Mater Sci. 1999;1:527-31.
13. Zhao XB, Courtney JM. Blood response to plasticized poly(vinyl chloride): dependence of fibrinogen adsorption on plasticizer selection and surface plasticizer level. J Mater Science: Mater Med. 2003;14:905-12.
14. Courtney JM, Lamba NMK, Sundaram S. Biomaterials for blood-contacting applications. Biomaterials. 1994;15:737-44.
15. Gorbet MB, Sefton MVM. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials. 2004;25:5681-703.
16. Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res. 2004;114:321-7.
17. Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD. Complement and coagulation: strangers or partners in crime? Trends Immunol. 2007;28:184-92.
18. Aignasse MF, Prognon P, Stachowicz M. A new simple and rapid HPLC method for determination of DEHP in PVC packaging and releasing studies. Int J Pharm. 1995;113:241-6.
19. Walport MJ. Complement. First of two parts. New Engl J Med. 2001;344:1058-66.
20. Walport MJ. Complement. Second of two parts. New Engl J Med. 2001;344:1140-4.
21. Szott LM, Stein MJ, Ratner BD. Complement activation on poly(ethylene oxide)-like radiofrequency glow discharge-deposited surfaces. J Biomed Mater Res A. 2011;96:150-61.
22. Hsu-Lin SC, Berman CL, Furie BC, August D, Furie B. A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets. J Biol Chem. 1984;259:9121-6.
23. Ratner BD. The catastrophe revisited: blood compatibility in the 21st century. Biomaterials. 2007;28:5144-7.
24. Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacob HS. Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin investig. 1977;59:879-88.
25. Seyfert UT, Biehl V, Schenk J. In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4. Bimol Eng. 2002;19:91-6.
26. ISO 10993-4:2002; Biological evaluation of medical devices e Part 4: selection of tests for interactions with blood.
27. Lamba MK, Courtney JM, Gaylor JDS, Lowe GDO. In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response. Biomaterials. 2000;21:89-96.
28. Engberg AE, Rosengren-Holmberg JP, Chen H. Blood protein-polymer adsorption: implications for understanding complement-mediated hemoincompatibility. J Biomed Res A. 2011;97:74-84.
29. Fink H, Hong J, Drotz K. An in vitro study of blood compatibility of vascular grafts made of bacterial cellulose in comparison with conventionally-used graft materials. J Biomed Mater Res A. 2011;97:52-8.
30. Schmaier AH. Contact activation: a revision. Thromb Haemost. 1997;77:101-7.
31. Oslakovic C, Edervall CT, Linse S, Dahlbäck B. Polystyrene nanoparticles affecting blood coagulation. Nanomed: Nanotechnol Biol Med. 2012;8:981-6.
32. Thierry B, Merhi Y, Silver J, Tabrizian M. Biodegradable membrane-covered stent from chitosan-based polymers. J Biomed Mater Res A. 2005;75:556-66.
33. Keuren JF, Wielders SJ, Driessen A, Hendriks VM, Lindhout T. Covalently-bound heparin makes collagen thromboresistant. Arterioscler Thromb Vasc Biol. 2004;24:613-7.
34. McMichael AJ, Beverly PCL, Cobbold S, Crumpton MJ, Gilks W, Gotch FM. Leukocyte typing III. Oxford: Oxford University Press Inc; 1987.